The United Nations adopted a new Political Declaration on HIV/AIDS this week following a 149-8 vote, though the process revealed deep fractures among member states regarding human rights language and intellectual property. The United States, Russia, Israel, and five other nations voted against the text, citing disagreements over “divisive topics” and trade-related clauses that could impact pharmaceutical patent protections.
Why are member states divided on the HIV/AIDS declaration?
The opposition to the declaration stems from fundamental disagreements over how to address the global epidemic. According to US Ambassador Tammy Bruce, the United States voted against the document because it moved away from the established 95-95-95 targets by including “divisive topics” and language that lacked consensus. The 95-95-95 targets, adopted in 2021, aim to ensure 95% of people living with HIV know their status, 95% are on antiretroviral treatment, and 95% of those on treatment achieve viral suppression.
Russia, meanwhile, cited “at least 20 unacceptable provisions,” specifically pointing to language that promotes “scientifically dubious notions” regarding harm reduction. Russia continues to favor the criminalization of drug use, standing in direct opposition to the declaration’s call for ending discrimination against people who inject drugs.
The declaration highlights that HIV infections rose by 77% in the Middle East and North Africa between 2010 and 2025, despite the global goal of ending AIDS as a public health threat by 2030.
How do trade disputes impact global access to medicine?
A significant point of contention involves the transfer of technology for HIV treatments. The Africa Group, represented by Malawi’s Madalitso Baloyi, successfully pushed to remove the phrase “mutually agreed terms” from the text regarding technology transfer. The group argues that keeping such language undermines the ability of developing nations to produce their own medicines and vaccines.
The United States expressed “deep concern” over these clauses. Ambassador Bruce stated that the US maintains a “longstanding position on intellectual property protection.” Switzerland and Canada also distanced themselves from these specific paragraphs, reflecting a broader tension between pharmaceutical patent holders and countries seeking to lower barriers to generic medical production during health emergencies.
What role does “key populations” language play in HIV policy?
The European Union, led by Cyprus, successfully amended the declaration to include human rights-based terminology, specifically referencing “key populations” and “sexual and reproductive health services.” Cyprus noted that these groups—which include sex workers, gay men, and people who inject drugs—face HIV prevalence rates up to 25 times higher than the general population.
While the EU advocates for an inclusive, evidence-based response, countries including Belarus, Burundi, and Senegal joined Russia in criticizing the promotion of “non-consensus-based language on gender.” This ideological divide suggests that future HIV negotiations will continue to struggle with the intersection of public health policy and domestic social legislation.
Pro Tip: Tracking HIV Funding Gaps
Industry observers should monitor the $3.2 billion funding shortfall reported for 2024. With external funding accounting for up to 80% of HIV prevention in sub-Saharan Africa, according to the declaration, shifts in development assistance could drastically alter the success of national prevention programs.
Frequently Asked Questions
- What are the 95-95-95 targets?
These are global goals established in 2021 to ensure 95% of people with HIV know their status, 95% are on treatment, and 95% of those treated are virally suppressed. - Why did the US vote against the declaration?
The US cited the inclusion of “divisive topics,” lack of consensus on certain documents, and concerns over intellectual property provisions related to technology transfer. - What is the “key populations” strategy?
It is an approach focusing on groups at highest risk of HIV, such as sex workers and people who inject drugs, who often face structural barriers to healthcare.
What do you think is the biggest barrier to reaching the 2030 goal of ending AIDS? Share your thoughts in the comments below or sign up for our newsletter for updates on global health policy.
